Studies have found that the expression of MCP-4 is elevated in various diseases, such as asthma (15), nephritis (16), atherosclerosis (17), atopic dermatitis (18), and rheumatoid arthritis (19). This evidence concerns the gene CCL13 and atopic eczema.